---
$id: https://graph.org.ai/products/commodity/51281618
$type: Product
source: UNSPSC
code: "51281618"
title: "Neomycin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Neomycin

**UNSPSC Code**: 51281618
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H46N6O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I16QD7X297, more generally known as neomycin. European Medicines Agency schedules neomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03406MIG. The term NEOMYCIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 32, no 10 1978, list 18. NEOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule neomycin under HS 29419000 and SITC 54139. As of Q4 2014, NEOMYCIN remains the US FDA Preferred Term for this commodity. Neomycin bears US NLM identifiers UMLS ID C0027603 and NCI Concept Code C683. SMILES: C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.

